^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Promitil (pegylated liposomal mitomycin-c prodrug)

    i
    Associations

    News

    Trials
    Company:
    LipoMedix
    Drug class:
    DNA synthesis inhibitor, Alkylating agent
    Related drugs:
    Associations

    News

    Trials
    10ms
    Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy (clinicaltrials.gov)
    P2, N=20, Recruiting, Lipomedix Pharmaceuticals Inc.
    New P2 trial
    |
    BRCA (Breast cancer early onset)
    |
    Promitil (pegylated liposomal mitomycin-c prodrug)